Department of Neurology, Yale School of Medicine, New Haven, CT, United States.
Department of Pulmonary Critical Care, Yale School of Medicine, New Haven, CT, United States.
Resuscitation. 2023 Jul;188:109832. doi: 10.1016/j.resuscitation.2023.109832. Epub 2023 May 11.
Early, accurate outcome prediction after out-of-hospital cardiac arrest (OHCA) is critical for clinical decision-making and resource allocation. We sought to validate the revised post-Cardiac Arrest Syndrome for Therapeutic hypothermia (rCAST) score in a United States cohort and compare its prognostic performance to the Pittsburgh Cardiac Arrest Category (PCAC) and Full Outline of UnResponsiveness (FOUR) scores.
This is a single-center, retrospective study of OHCA patients admitted between January 2014-August 2022. Area under the receiver operating curve (AUC) was computed for each score for predicting poor neurologic outcome at discharge and in-hospital mortality. We compared the scores' predictive abilities via Delong's test.
Of 505 OHCA patients with all scores available, the medians [IQR] for rCAST, PCAC, and FOUR scores were 9.5 [6.0, 11.5], 4 [3, 4], and 2 [0, 5], respectively. The AUC [95% confidence interval] of the rCAST, PCAC, and FOUR scores for predicting poor neurologic outcome were 0.815 [0.763-0.867], 0.753 [0.697-0.809], and 0.841 [0.796-0.886], respectively. The AUC [95% confidence interval] of the rCAST, PCAC, and FOUR scores for predicting mortality were 0.799 [0.751-0.847], 0.723 [0.673-0.773], and 0.813 [0.770-0.855], respectively. The rCAST score was superior to the PCAC score for predicting mortality (p = 0.017). The FOUR score was superior to the PCAC score for predicting poor neurological outcome (p < 0.001) and mortality (p < 0.001).
The rCAST score can reliably predict poor outcome in a United States cohort of OHCA patients regardless of TTM status and outperforms the PCAC score.
院外心脏骤停(OHCA)后早期、准确的预后预测对于临床决策和资源分配至关重要。我们旨在验证修订后的心脏骤停后综合征用于治疗性低温(rCAST)评分在美国队列中的有效性,并比较其预后性能与匹兹堡心脏骤停分类(PCAC)和全面无反应性(FOUR)评分。
这是一项单中心、回顾性研究,纳入了 2014 年 1 月至 2022 年 8 月期间入院的 OHCA 患者。计算每个评分预测出院时和住院期间不良神经结局以及死亡率的受试者工作特征曲线(ROC)下面积(AUC)。我们通过 Delong 检验比较了这些评分的预测能力。
在纳入了所有评分的 505 例 OHCA 患者中,rCAST、PCAC 和 FOUR 评分的中位数(IQR)分别为 9.5 [6.0, 11.5]、4 [3, 4] 和 2 [0, 5]。rCAST、PCAC 和 FOUR 评分预测不良神经结局的 AUC [95%置信区间]分别为 0.815 [0.763-0.867]、0.753 [0.697-0.809]和 0.841 [0.796-0.886]。rCAST、PCAC 和 FOUR 评分预测死亡率的 AUC [95%置信区间]分别为 0.799 [0.751-0.847]、0.723 [0.673-0.773]和 0.813 [0.770-0.855]。rCAST 评分在预测死亡率方面优于 PCAC 评分(p = 0.017)。FOUR 评分在预测不良神经结局(p < 0.001)和死亡率(p < 0.001)方面优于 PCAC 评分。
rCAST 评分可可靠地预测美国 OHCA 患者的不良结局,无论 TTM 状态如何,且优于 PCAC 评分。